English (United Kingdom)

https://curated-unify.zendy.io/wp-json/zendy-region/v1/featured_content/oa?rat=en

https://curated-unify.zendy.io/wp-json/zendy-region/v1/highlighted_journal/

Global: Zendy Tools annual

Presents the keyphrase highlighting as premium feature

Keyphrase Highlighting

Presents the summarisation as premium feature

Summarisation

Insights

Presents the pdf analysis as premium feature

PDF Analysis

Presents the zaia usage as premium feature

ZAIA

Global: Zendy Tools monthly

Global: Zendy Plus monthly

Presents the access of premium content as premium feature

Premium Content

Global: Zendy Plus annual

Global: Zendy Free Plan

Bagamoyo Research and Training Centre (BRTC), a branch of the Ifakara Health Institute (IHI), established in late 2004, has evolved into a leading site in performing high-quality Phase II and Phase III malaria vaccine and drug trials according to ICH/GCP standards. Several Phase II and III trials and assessments of interventions focused on better diagnosis, treatment and prevention of malaria have been completed successfully. Expansion into the areas of TB, with the set up of a new BSL-3, and HIV/AIDS marks the commitment of the site to developing into a regional centre of excellence for both clinical trials and epidemiological research.

The Ifakara Health Institute's Bagamoyo Research and Training Centre: a well-established clinical trials site in Tanzania